Half-year report · Q2
2931.TEDINET S100U6LW
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥46.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥348m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | −¥760m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥309m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥1.4bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥639m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥476m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥618m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥267m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥914m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥235m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | −¥913m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥70.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥59.6bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥60.8bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.0bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥39.4bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.3bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥21.7bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.1bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥18.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥16m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥658m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥500m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥361m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥646m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥351m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥507m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.8bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.02 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.76 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.88 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.5% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.9% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥811m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥306m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥306m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥251m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥22.0bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥22.0bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.7bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥242m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥862m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥432m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥724m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥189m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥101m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 659
| Item | Context | Value | Unit |
|---|---|---|---|
| Non operating expenses | Prior1YTDDuration | 327000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 297000000 | JPY |
| Ordinary income | Prior1YTDDuration | -639000000 | JPY |
| Ordinary income | CurrentYTDDuration | 309000000 | JPY |
| Gain on reversal of subscription rights to shares ei | Prior1YTDDuration | 1000000 | JPY |
| Gain on reversal of subscription rights to shares ei | CurrentYTDDuration | 0 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 33000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 52000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | - | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 329000000 | JPY |
| Gain on valuation of investment securities ei | Prior1YTDDuration | - | JPY |
| Gain on valuation of investment securities ei | CurrentYTDDuration | 15000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 34000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 398000000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | 7000000 | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | - | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | 5000000 | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | - | JPY |
| Loss on sales of stocks of subsidiaries and affiliates el | Prior1YTDDuration | - | JPY |
| Loss on sales of stocks of subsidiaries and affiliates el | CurrentYTDDuration | 88000000 | JPY |
| Impairment loss el | Prior1YTDDuration | - | JPY |
| Impairment loss el | CurrentYTDDuration | 1094000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 13000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 1183000000 | JPY |
| Income before income taxes | Prior1YTDDuration | -618000000 | JPY |
| Income before income taxes | CurrentYTDDuration | -476000000 | JPY |
| Income taxes current | Prior1YTDDuration | 511000000 | JPY |
| Income taxes current | CurrentYTDDuration | 475000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | -217000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -716000000 | JPY |
| Income taxes | Prior1YTDDuration | 294000000 | JPY |
| Income taxes | CurrentYTDDuration | -241000000 | JPY |
| Profit loss | Prior1YTDDuration | -913000000 | JPY |
| Profit loss | CurrentYTDDuration | -235000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 0 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 32000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | -914000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | -267000000 | JPY |
| Profit loss | Prior1YTDDuration | -913000000 | JPY |
| Profit loss | CurrentYTDDuration | -235000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 2000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -85000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | -1000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | -2000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 25000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | -6000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -1000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -1000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 4000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 5000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |